{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,9]],"date-time":"2026-01-09T21:17:45Z","timestamp":1767993465567,"version":"3.49.0"},"reference-count":60,"publisher":"Springer Science and Business Media LLC","issue":"4","license":[{"start":{"date-parts":[[2017,11,2]],"date-time":"2017-11-02T00:00:00Z","timestamp":1509580800000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"funder":[{"name":"National Cerebral and Cardiovascular Center","award":["28-6-18"],"award-info":[{"award-number":["28-6-18"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Heart Vessels"],"published-print":{"date-parts":[[2018,4]]},"DOI":"10.1007\/s00380-017-1071-7","type":"journal-article","created":{"date-parts":[[2017,11,2]],"date-time":"2017-11-02T17:43:29Z","timestamp":1509644609000},"page":"385-392","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":12,"title":["Increased serum Wisteria floribunda agglutinin positive Mac-2 binding protein (Mac-2 binding protein glycosylation isomer) in chronic heart failure: a pilot study"],"prefix":"10.1007","volume":"33","author":[{"given":"Atsushi","family":"Okada","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hideaki","family":"Kanzaki","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yasuhiro","family":"Hamatani","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Seiji","family":"Takashio","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hiroyuki","family":"Takahama","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Makoto","family":"Amaki","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Takuya","family":"Hasegawa","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yasuo","family":"Sugano","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Satoshi","family":"Yasuda","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Toshihisa","family":"Anzai","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2017,11,2]]},"reference":[{"key":"1071_CR1","doi-asserted-by":"crossref","first-page":"1947","DOI":"10.1016\/j.athoracsur.2012.06.057","volume":"94","author":"R Arif","year":"2012","unstructured":"Arif R, Seppelt P, Schwill S, Kojic D, Ghodsizad A, Ruhparwar A, Karck M, Kallenbach K (2012) Predictive risk factors for patients with cirrhosis undergoing heart surgery. Ann Thorac Surg 94:1947\u20131952","journal-title":"Ann Thorac Surg"},{"key":"1071_CR2","doi-asserted-by":"crossref","first-page":"12608","DOI":"10.3748\/wjg.v20.i35.12608","volume":"20","author":"CH Lin","year":"2014","unstructured":"Lin CH, Hsu RB (2014) Cardiac surgery in patients with liver cirrhosis: risk factors for predicting mortality. World J Gastroenterol 20:12608\u201312614","journal-title":"World J Gastroenterol"},{"key":"1071_CR3","doi-asserted-by":"crossref","first-page":"500","DOI":"10.1016\/j.athoracsur.2003.06.021","volume":"77","author":"N Hayashida","year":"2004","unstructured":"Hayashida N, Shoujima T, Teshima H, Yokokura Y, Takagi K, Tomoeda H, Aoyagi S (2004) Clinical outcome after cardiac operations in patients with cirrhosis. Ann Thorac Surg 77:500\u2013505","journal-title":"Ann Thorac Surg"},{"key":"1071_CR4","doi-asserted-by":"crossref","first-page":"719","DOI":"10.1016\/S1542-3565(04)00296-4","volume":"2","author":"A Suman","year":"2004","unstructured":"Suman A, Barnes DS, Zein NN, Levinthal GN, Connor JT, Carey WD (2004) Predicting outcome after cardiac surgery in patients with cirrhosis: a comparison of Child-Pugh and MELD scores. Clin Gastroenterol Hepatol 2:719\u2013723","journal-title":"Clin Gastroenterol Hepatol"},{"key":"1071_CR5","doi-asserted-by":"crossref","first-page":"293","DOI":"10.1007\/s11748-008-0374-0","volume":"57","author":"T Murashita","year":"2009","unstructured":"Murashita T, Komiya T, Tamura N, Sakaguchi G, Kobayashi T, Furukawa T, Matsushita A, Sunagawa G (2009) Preoperative evaluation of patients with liver cirrhosis undergoing open heart surgery. Gen Thorac Cardiovasc Surg 57:293\u2013297","journal-title":"Gen Thorac Cardiovasc Surg"},{"key":"1071_CR6","doi-asserted-by":"crossref","first-page":"811","DOI":"10.1016\/j.athoracsur.2009.12.021","volume":"89","author":"A Morisaki","year":"2010","unstructured":"Morisaki A, Hosono M, Sasaki Y, Kubo S, Hirai H, Suehiro S, Shibata T (2010) Risk factor analysis in patients with liver cirrhosis undergoing cardiovascular operations. Ann Thorac Surg 89:811\u2013817","journal-title":"Ann Thorac Surg"},{"key":"1071_CR7","doi-asserted-by":"crossref","first-page":"263","DOI":"10.1177\/0218492311435339","volume":"20","author":"Y Sugimura","year":"2012","unstructured":"Sugimura Y, Toyama M, Katoh M, Kato Y, Hisamoto K (2012) Analysis of open heart surgery in patients with liver cirrhosis. Asian Cardiovasc Thorac Ann 20:263\u2013268","journal-title":"Asian Cardiovasc Thorac Ann"},{"key":"1071_CR8","first-page":"647","volume":"56","author":"JC Lopez-Delgado","year":"2015","unstructured":"Lopez-Delgado JC, Esteve F, Javierre C, Torrado H, Carrio ML, Rodr\u00edguez-Castro D, Farrero E, Llu\u00eds Ventura J, Manez R (2015) Predictors of long-term mortality in patients with cirrhosis undergoing cardiac surgery. J Cardiovasc Surg (Torino) 56:647\u2013654","journal-title":"J Cardiovasc Surg (Torino)"},{"key":"1071_CR9","doi-asserted-by":"crossref","first-page":"2163","DOI":"10.1016\/j.jacc.2008.03.009","volume":"51","author":"JC Matthews","year":"2008","unstructured":"Matthews JC, Koelling TM, Pagani FD, Aaronson KD (2008) The right ventricular failure risk score a pre-operative tool for assessing the risk of right ventricular failure in left ventricular assist device candidates. J Am Coll Cardiol 51:2163\u20132172","journal-title":"J Am Coll Cardiol"},{"key":"1071_CR10","doi-asserted-by":"crossref","first-page":"1138","DOI":"10.1253\/circj.CJ-10-0986","volume":"75","author":"I Nakajima","year":"2011","unstructured":"Nakajima I, Kato TS, Komamura K, Takahashi A, Oda N, Sasaoka T, Asakura M, Hashimura K, Kitakaze M (2011) Pre- and post-operative risk factors associated with cerebrovascular accidents in patients supported by left ventricular assist device. Single center\u2019s experience in Japan. Circ J 75:1138\u20131146","journal-title":"Circ J"},{"key":"1071_CR11","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1253\/circj.CJ-10-0770","volume":"75","author":"T Shiga","year":"2011","unstructured":"Shiga T, Kinugawa K, Hatano M, Yao A, Nishimura T, Endo M, Kato N, Hirata Y, Kyo S, Ono M, Nagai R (2011) Age and preoperative total bilirubin level can stratify prognosis after extracorporeal pulsatile left ventricular assist device implantation. Circ J 75:121\u2013128","journal-title":"Circ J"},{"key":"1071_CR12","doi-asserted-by":"crossref","first-page":"601","DOI":"10.1016\/j.healun.2012.02.027","volume":"31","author":"JA Yang","year":"2012","unstructured":"Yang JA, Kato TS, Shulman BP, Takayama H, Farr M, Jorde UP, Mancini DM, Naka Y, Schulze PC (2012) Liver dysfunction as a predictor of outcomes in patients with advanced heart failure requiring ventricular assist device support: use of the Model of End-stage Liver Disease (MELD) and MELD eXcluding INR (MELD-XI) scoring system. J Heart Lung Transplant 31:601\u2013610","journal-title":"J Heart Lung Transplant"},{"key":"1071_CR13","doi-asserted-by":"crossref","first-page":"1895","DOI":"10.1253\/circj.CJ-12-0182","volume":"76","author":"T Imamura","year":"2012","unstructured":"Imamura T, Kinugawa K, Shiga T, Endo M, Kato N, Inaba T, Maki H, Hatano M, Yao A, Nishimura T, Hirata Y, Kyo S, Ono M, Nagai R (2012) Novel risk scoring system with preoperative objective parameters gives a good prediction of 1-year mortality in patients with a left ventricular assist device. Circ J 76:1895\u20131903","journal-title":"Circ J"},{"key":"1071_CR14","doi-asserted-by":"crossref","first-page":"404","DOI":"10.1007\/s10047-013-0724-2","volume":"16","author":"H Nishi","year":"2013","unstructured":"Nishi H, Toda K, Miyagawa S, Yoshikawa Y, Fukushima S, Yoshioka D, Saito T, Saito S, Sakaguchi T, Ueno T, Kuratani T, Sawa Y (2013) Prediction of outcome in patients with liver dysfunction after left ventricular assist device implantation. J Artif Organs 16:404\u2013410","journal-title":"J Artif Organs"},{"key":"1071_CR15","doi-asserted-by":"crossref","first-page":"34","DOI":"10.1016\/j.healun.2015.07.007","volume":"35","author":"AH Healy","year":"2016","unstructured":"Healy AH, Stehlik J, Edwards LB, McKellar SH, Drakos SG, Selzman CH (2016) Predictors of 30-day post-transplant mortality in patients bridged to transplantation with continuous-flow left ventricular assist devices\u2014an analysis of the International Society for Heart and Lung Transplantation Transplant Registry. J Heart Lung Transpl 35:34\u201339","journal-title":"J Heart Lung Transpl"},{"key":"1071_CR16","doi-asserted-by":"crossref","first-page":"287","DOI":"10.1097\/HCO.0000000000000288","volume":"31","author":"S Maltais","year":"2016","unstructured":"Maltais S, Stulak JM (2016) Right and left ventricular assist devices support and liver dysfunction: prognostic and therapeutic implications. Curr Opin Cardiol 31:287\u2013291","journal-title":"Curr Opin Cardiol"},{"key":"1071_CR17","first-page":"268","volume":"17","author":"M Kirsch","year":"1998","unstructured":"Kirsch M, Baufreton C, Naftel DC, Benvenuti C, Loisance DY (1998) Pretransplantation risk factors for death after heart transplantation: the Henri Mondor experience. J Heart Lung Transpl 17:268\u2013277","journal-title":"J Heart Lung Transpl"},{"key":"1071_CR18","doi-asserted-by":"crossref","first-page":"307","DOI":"10.1016\/j.ejcts.2008.05.003","volume":"34","author":"RB Hsu","year":"2008","unstructured":"Hsu RB, Chang CI, Lin FY, Chou NK, Chi NH, Wang SS, Chu SH (2008) Heart transplantation in patients with liver cirrhosis. Eur J Cardiothorac Surg 34:307\u2013312","journal-title":"Eur J Cardiothorac Surg"},{"key":"1071_CR19","doi-asserted-by":"crossref","first-page":"591","DOI":"10.1016\/j.healun.2012.02.008","volume":"31","author":"A Chokshi","year":"2012","unstructured":"Chokshi A, Cheema FH, Schaefle KJ, Jiang J, Collado E, Shahzad K, Khawaja T, Farr M, Takayama H, Naka Y, Mancini DM, Schulze PC (2012) Hepatic dysfunction and survival after orthotopic heart transplantation: application of the MELD scoring system for outcome prediction. J Heart Lung Transpl 31:591\u2013600","journal-title":"J Heart Lung Transpl"},{"key":"1071_CR20","doi-asserted-by":"crossref","first-page":"491","DOI":"10.1136\/heartjnl-2012-303347","volume":"99","author":"GE Assenza","year":"2013","unstructured":"Assenza GE, Graham DA, Landzberg MJ, Valente AM, Singh MN, Bashir A, Fernandes S, Mortele KJ, Ukomadu C, Volpe M, Wu F (2013) MELD-XI score and cardiac mortality or transplantation in patients after Fontan surgery. Heart 99:491\u2013496","journal-title":"Heart"},{"key":"1071_CR21","doi-asserted-by":"crossref","first-page":"1737","DOI":"10.1016\/j.athoracsur.2015.07.026","volume":"100","author":"JC Grimm","year":"2015","unstructured":"Grimm JC, Shah AS, Magruder JT, Kilic A, Valero V 3rd, Dungan SP, Tedford RJ, Russell SD, Whitman GJ, Sciortino CM (2015) MELD-XI score predicts early mortality in patients after heart transplantation. Ann Thorac Surg 100:1737\u20131743","journal-title":"Ann Thorac Surg"},{"key":"1071_CR22","doi-asserted-by":"crossref","first-page":"730","DOI":"10.1016\/j.athoracsur.2015.06.063","volume":"101","author":"JC Grimm","year":"2016","unstructured":"Grimm JC, Magruder JT, Do N, Spinner JA, Dungan SP, Kilic A, Patel N, Nelson KL, Jacobs ML, Cameron DE, Vricella LA (2016) Modified model for end-stage liver disease eXcluding INR (MELD-XI) score predicts early death after pediatric heart transplantation. Ann Thorac Surg 101:730\u2013735","journal-title":"Ann Thorac Surg"},{"key":"1071_CR23","doi-asserted-by":"crossref","first-page":"222","DOI":"10.1016\/j.healun.2015.10.008","volume":"35","author":"SV Deo","year":"2016","unstructured":"Deo SV, Al-Kindi SG, Altarabsheh SE, Hang D, Kumar S, Ginwalla MB, ElAmm CA, Sareyyupoglu B, Medalion B, Oliveira GH, Park SJ (2016) Model for end-stage liver disease excluding international normalized ratio (MELD-XI) score predicts heart transplant outcomes: evidence from the registry of the United Network for Organ Sharing. J Heart Lung Transpl 35:222\u2013227","journal-title":"J Heart Lung Transpl"},{"key":"1071_CR24","doi-asserted-by":"crossref","first-page":"2352","DOI":"10.1161\/CIRCULATIONAHA.108.814863","volume":"120","author":"SD Russell","year":"2009","unstructured":"Russell SD, Rogers JG, Milano CA, Dyke DB, Pagani FD, Aranda JM, Klodell CT Jr, Boyle AJ, John R, Chen L, Massey HT, Farrar DJ, Conte JV, HeartMate II Clinical Investigators (2009) Renal and hepatic function improve in advanced heart failure patients during continuous-flow support with the HeartMate II left ventricular assist device. Circulation 120:2352\u20132357","journal-title":"Circulation"},{"key":"1071_CR25","doi-asserted-by":"crossref","first-page":"395","DOI":"10.1007\/s10047-012-0654-4","volume":"15","author":"T Imamura","year":"2012","unstructured":"Imamura T, Kinugawa K, Shiga T, Kato N, Endo M, Inaba T, Maki H, Hatano M, Yao A, Hirata Y, Akahane M, Nishimura T, Kyo S, Ono M, Nagai R (2012) How to demonstrate the reversibility of end-organ function before implantation of left ventricular assist device in INTERMACS profile 2 patients? J Artif Organs 15:395\u2013398","journal-title":"J Artif Organs"},{"key":"1071_CR26","doi-asserted-by":"crossref","first-page":"96","DOI":"10.1253\/circj.CJ-12-0686","volume":"77","author":"T Imamura","year":"2013","unstructured":"Imamura T, Kinugawa K, Shiga T, Endo M, Kato N, Inaba T, Maki H, Hatano M, Yao A, Nishimura T, Hirata Y, Kyo S, Ono M, Nagai R (2013) Preoperative levels of bilirubin or creatinine adjusted by age can predict their reversibility after implantation of left ventricular assist device. Circ J 77:96\u2013104","journal-title":"Circ J"},{"key":"1071_CR27","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1161\/CIRCHEARTFAILURE.109.872556","volume":"3","author":"JM Gelow","year":"2010","unstructured":"Gelow JM, Desai AS, Hochberg CP, Glickman JN, Givertz MM, Fang JC (2010) Clinical predictors of hepatic fibrosis in chronic advanced heart failure. Circ Heart Fail 3:59\u201364","journal-title":"Circ Heart Fail"},{"key":"1071_CR28","doi-asserted-by":"crossref","first-page":"419","DOI":"10.1111\/jocs.12318","volume":"29","author":"ZT Demirozu","year":"2014","unstructured":"Demirozu ZT, Hernandez R, Mallidi HR, Singh SK, Radovancevic R, Segura AM, Etheridge WB, Cohn WE, Frazier OH (2014) HeartMate II left ventricular assist device implantation in patients with advanced hepatic dysfunction. J Card Surg 29:419\u2013423","journal-title":"J Card Surg"},{"key":"1071_CR29","doi-asserted-by":"crossref","first-page":"932","DOI":"10.1038\/modpathol.2015.40","volume":"28","author":"CY Louie","year":"2015","unstructured":"Louie CY, Pham MX, Daugherty TJ, Kambham N, Higgins JP (2015) The liver in heart failure: a biopsy and explant series of the histopathologic and laboratory findings with a particular focus on pre-cardiac transplant evaluation. Mod Pathol 28:932\u2013943","journal-title":"Mod Pathol"},{"key":"1071_CR30","doi-asserted-by":"crossref","first-page":"873","DOI":"10.1016\/j.healun.2014.12.009","volume":"34","author":"M Farr","year":"2015","unstructured":"Farr M, Mitchell J, Lippel M, Kato TS, Jin Z, Ippolito P, Dove L, Jorde UP, Takayama H, Emond J, Naka Y, Mancini D, Lefkowitch JH, Schulze PC (2015) Combination of liver biopsy with MELD-XI scores for post-transplant outcome prediction in patients with advanced heart failure and suspected liver dysfunction. J Heart Lung Transpl 34:873\u2013882","journal-title":"J Heart Lung Transpl"},{"key":"1071_CR31","first-page":"67","volume":"22","author":"A Parera","year":"1999","unstructured":"Parera A, Ba\u00f1ares R, Alvarez R, Casariego J, Carneros JA, Salcedo M, Palomo J, Cos E (1999) The usefulness of transjugular hepatic biopsy in the evaluation of liver disease in candidates for heart transplantation. Gastroenterol Hepatol 22:67\u201371","journal-title":"Gastroenterol Hepatol"},{"key":"1071_CR32","doi-asserted-by":"crossref","first-page":"505","DOI":"10.1136\/hrt.78.5.505","volume":"78","author":"Y Sato","year":"1997","unstructured":"Sato Y, Kataoka K, Matsumori A, Sasayama S, Yamada T, Ito H, Takatsu Y (1997) Measuring serum aminoterminal type III procollagen peptide, 7S domain of type IV collagen, and cardiac troponin T in patients with idiopathic dilated cardiomyopathy and secondary cardiomyopathy. Heart 78:505\u2013508","journal-title":"Heart"},{"key":"1071_CR33","doi-asserted-by":"crossref","first-page":"549","DOI":"10.1016\/S0003-4975(01)03510-X","volume":"73","author":"T Masai","year":"2002","unstructured":"Masai T, Sawa Y, Ohtake S, Nishida T, Nishimura M, Fukushima N, Yamaguchi T, Matsuda H (2002) Hepatic dysfunction after left ventricular mechanical assist in patients with end-stage heart failure: role of inflammatory response and hepatic microcirculation. Ann Thorac Surg 73:549\u2013555","journal-title":"Ann Thorac Surg"},{"key":"1071_CR34","first-page":"175","volume":"21","author":"G Li","year":"2006","unstructured":"Li G, Yan QB, Wei LM (2006) Serum concentrations of hyaluronic acid, procollagen type III NH2-terminal peptide, and laminin in patients with chronic congestive heart failure. Chin Med Sci J 21:175\u2013178","journal-title":"Chin Med Sci J"},{"key":"1071_CR35","doi-asserted-by":"crossref","first-page":"683","DOI":"10.1586\/14789450.2015.1084874","volume":"12","author":"H Narimatsu","year":"2015","unstructured":"Narimatsu H (2015) Development of M2BPGi: a novel fibrosis serum glyco-biomarker for chronic hepatitis\/cirrhosis diagnostics. Expert Rev Proteomics 12:683\u2013693","journal-title":"Expert Rev Proteomics"},{"key":"1071_CR36","doi-asserted-by":"crossref","first-page":"1065","DOI":"10.1038\/srep01065","volume":"3","author":"A Kuno","year":"2013","unstructured":"Kuno A, Ikehara Y, Tanaka Y, Ito K, Matsuda A, Sekiya S, Hige S, Sakamoto M, Kage M, Mizokami M, Narimatsu H (2013) A serum \u201csweet-doughnut\u201d protein facilitates fibrosis evaluation and therapy assessment in patients with viral hepatitis. Sci Rep 3:1065","journal-title":"Sci Rep"},{"key":"1071_CR37","doi-asserted-by":"crossref","first-page":"1199","DOI":"10.1161\/CIRCHEARTFAILURE.113.000403","volume":"6","author":"R Eschalier","year":"2013","unstructured":"Eschalier R, Fertin M, Fay R, Bauters C, Zannad F, Pinet F, Rossignol P (2013) Extracellular matrix turnover biomarkers predict long-term left ventricular remodeling after myocardial infarction: insights from the REVE-2 study. Circ Heart Fail 6:1199\u20131205","journal-title":"Circ Heart Fail"},{"key":"1071_CR38","doi-asserted-by":"crossref","first-page":"642","DOI":"10.1002\/prca.201300010","volume":"7","author":"A Kuno","year":"2013","unstructured":"Kuno A, Sato T, Shimazaki H, Unno S, Saitou K, Kiyohara K, Sogabe M, Tsuruno C, Takahama Y, Ikehara Y, Narimatsu H (2013) Reconstruction of a robust glycodiagnostic agent supported by multiple lectin-assisted glycan profiling. Proteomics Clin Appl 7:642\u2013647","journal-title":"Proteomics Clin Appl"},{"key":"1071_CR39","doi-asserted-by":"crossref","first-page":"2253","DOI":"10.1016\/j.jacc.2012.12.056","volume":"61","author":"MS Kim","year":"2013","unstructured":"Kim MS, Kato TS, Farr M, Wu C, Givens RC, Collado E, Mancini DM, Schulze PC (2013) Hepatic dysfunction in ambulatory patients with heart failure: application of the MELD scoring system for outcome prediction. J Am Coll Cardiol 61:2253\u20132261","journal-title":"J Am Coll Cardiol"},{"key":"1071_CR40","doi-asserted-by":"crossref","first-page":"777","DOI":"10.1016\/S0894-7317(03)00335-3","volume":"16","author":"WA Zoghbi","year":"2003","unstructured":"Zoghbi WA, Enriquez-Sarano M, Foster E, Grayburn PA, Kraft CD, Levine RA, Nihoyannopoulos P, Otto CM, Quinones MA, Rakowski H, Stewart WJ, Waggoner A, Weissman NJ, American Society of Echocardiography (2003) Recommendations for evaluation of the severity of native valvular regurgitation with two-dimensional and Doppler echocardiography. J Am Soc Echocardiogr 16:777\u2013802","journal-title":"J Am Soc Echocardiogr"},{"key":"1071_CR41","doi-asserted-by":"crossref","first-page":"1440","DOI":"10.1016\/j.echo.2005.10.005","volume":"18","author":"RM Lang","year":"2005","unstructured":"Lang RM, Bierig M, Devereux RB, Flachskampf FA, Foster E, Pellikka PA, Picard MH, Roman MJ, Seward J, Shanewise JS, Solomon SD, Spencer KT, Sutton MS, Stewart WJ (2005) Recommendations for chamber quantification: a report from the American Society of Echocardiography\u2019s Guidelines and Standards Committee and the Chamber Quantification Writing Group, developed in conjunction with the European Association of Echocardiography, a branch of the European Society of Cardiology. J Am Soc Echocardiogr 18:1440\u20131463","journal-title":"J Am Soc Echocardiogr"},{"key":"1071_CR42","doi-asserted-by":"crossref","first-page":"1441","DOI":"10.1056\/NEJM197112232852601","volume":"285","author":"PA McKee","year":"1971","unstructured":"McKee PA, Castelli WP, McNamara PM, Kannel WB (1971) The natural history of congestive heart failure: the Framingham study. N Engl J Med 285:1441\u20131446","journal-title":"N Engl J Med"},{"key":"1071_CR43","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1111\/liv.13188","volume":"37","author":"X Zou","year":"2017","unstructured":"Zou X, Zhu MY, Yu DM, Li W, Zhang DH, Lu FJ, Gong QM, Liu F, Jiang JH, Zheng MH, Kuno A, Narimatsu H, Zhang Y, Zhang XX (2017) Serum WFA+-M2BP levels for evaluation of early stages of liver fibrosis in patients with chronic hepatitis B virus infection. Liver Int 37:35\u201344","journal-title":"Liver Int"},{"key":"1071_CR44","doi-asserted-by":"crossref","first-page":"E74","DOI":"10.1111\/hepr.12724","volume":"47","author":"H Nishikawa","year":"2017","unstructured":"Nishikawa H, Takata R, Enomoto H, Yoh K, Kishino K, Shimono Y, Iwata Y, Hasegawa K, Nakano C, Nishimura T, Aizawa N, Sakai Y, Ikeda N, Takashima T, Ishii A, Iijima H, Nishiguchi S (2017) Proposal of a predictive model for advanced fibrosis containing Wisteria floribunda agglutinin-positive Mac-2-binding protein in chronic hepatitis C. Hepatol Res 47:E74\u2013E84","journal-title":"Hepatol Res"},{"key":"1071_CR45","doi-asserted-by":"crossref","first-page":"956","DOI":"10.1007\/s12072-016-9754-1","volume":"10","author":"H Nagata","year":"2016","unstructured":"Nagata H, Nakagawa M, Nishimura-Sakurai Y, Asano Y, Tsunoda T, Miyoshi M, Kaneko S, Goto F, Otani S, Kawai-Kitahata F, Murakawa M, Nitta S, Itsui Y, Azuma S, Kakinuma S, Tojo N, Tohda S, Asahina Y, Watanabe M, Ochanomizu Liver Conference Study Group (2016) Serial measurement of Wisteria floribunda agglutinin positive Mac-2-binding protein is useful for predicting liver fibrosis and the development of hepatocellular carcinoma in chronic hepatitis C patients treated with IFN-based and IFN-free therapy. Hepatol Int 10:956\u2013964","journal-title":"Hepatol Int"},{"key":"1071_CR46","doi-asserted-by":"crossref","first-page":"776","DOI":"10.1007\/s00535-014-1007-2","volume":"50","author":"M Abe","year":"2015","unstructured":"Abe M, Miyake T, Kuno A, Imai Y, Sawai Y, Hino K, Hara Y, Hige S, Sakamoto M, Yamada G, Kage M, Korenaga M, Hiasa Y, Mizokami M, Narimatsu H (2015) Association between Wisteria floribunda agglutinin-positive Mac-2 binding protein and the fibrosis stage of non-alcoholic fatty liver disease. J Gastroenterol 50:776\u2013784","journal-title":"J Gastroenterol"},{"key":"1071_CR47","doi-asserted-by":"crossref","first-page":"e0174982","DOI":"10.1371\/journal.pone.0174982","volume":"12","author":"LL Lai","year":"2017","unstructured":"Lai LL, Chan WK, Sthaneshwar P, Nik Mustapha NR, Goh KL, Mahadeva S (2017) Serum Wisteria floribunda agglutinin-positive Mac-2 binding protein in non-alcoholic fatty liver disease. PLoS One 12:e0174982","journal-title":"PLoS One"},{"key":"1071_CR48","doi-asserted-by":"crossref","first-page":"613","DOI":"10.1111\/hepr.12596","volume":"46","author":"H Nishikawa","year":"2016","unstructured":"Nishikawa H, Enomoto H, Iwata Y, Hasegawa K, Nakano C, Takata R, Nishimura T, Yoh K, Aizawa N, Sakai Y, Ikeda N, Takashima T, Iijima H, Nishiguchi S (2016) Clinical significance of serum Wisteria floribunda agglutinin positive Mac-2-binding protein level and high-sensitivity C-reactive protein concentration in autoimmune hepatitis. Hepatol Res 46:613\u2013621","journal-title":"Hepatol Res"},{"key":"1071_CR49","doi-asserted-by":"crossref","first-page":"857","DOI":"10.1038\/ajg.2015.118","volume":"110","author":"T Umemura","year":"2015","unstructured":"Umemura T, Joshita S, Sekiguchi T, Usami Y, Shibata S, Kimura T, Komatsu M, Matsumoto A, Ota M, Tanaka E (2015) Serum Wisteria floribunda agglutinin-positive Mac-2-binding protein level predicts liver fibrosis and prognosis in primary biliary cirrhosis. Am J Gastroenterol 110:857\u2013864","journal-title":"Am J Gastroenterol"},{"key":"1071_CR50","doi-asserted-by":"crossref","first-page":"1387","DOI":"10.1111\/jgh.13708","volume":"32","author":"Y Bekki","year":"2017","unstructured":"Bekki Y, Yoshizumi T, Shimoda S, Itoh S, Harimoto N, Ikegami T, Kuno A, Narimatsu H, Shirabe K, Maehara Y (2017) Hepatic stellate cells secreting WFA+-M2BP: its role in biological interactions with Kupffer cells. J Gastroenterol Hepatol 32:1387\u20131393","journal-title":"J Gastroenterol Hepatol"},{"key":"1071_CR51","doi-asserted-by":"crossref","first-page":"932","DOI":"10.1007\/s00380-017-0954-y","volume":"32","author":"Y Takaya","year":"2017","unstructured":"Takaya Y, Yoshihara F, Yokoyama H, Kanzaki H, Kitakaze M, Goto Y, Anzai T, Yasuda S, Ogawa H, Kawano Y, Kangawa K (2017) Impact of decreased serum albumin levels on acute kidney injury in patients with acute decompensated heart failure: a potential association of atrial natriuretic peptide. Heart Vessels 32:932\u2013943","journal-title":"Heart Vessels"},{"key":"1071_CR52","doi-asserted-by":"crossref","first-page":"204","DOI":"10.1007\/s00380-014-0469-8","volume":"30","author":"T Sato","year":"2015","unstructured":"Sato T, Yamauchi H, Suzuki S, Yoshihisa A, Yamaki T, Sugimoto K, Kunii H, Nakazato K, Suzuki H, Saitoh S, Takeishi Y (2015) Serum cholinesterase is an important prognostic factor in chronic heart failure. Heart Vessels 30:204\u2013210","journal-title":"Heart Vessels"},{"key":"1071_CR53","doi-asserted-by":"crossref","first-page":"46","DOI":"10.1016\/j.rmed.2016.04.013","volume":"115","author":"M Kono","year":"2016","unstructured":"Kono M, Nakamura Y, Oyama Y, Mori K, Hozumi H, Karayama M, Hashimoto D, Enomoto N, Fujisawa T, Inui N, Yamada M, Hamada E, Colby TV, Maekawa M, Suda T (2016) Increased levels of serum Wisteria floribunda agglutinin-positive Mac-2 binding protein in idiopathic pulmonary fibrosis. Respir Med 115:46\u201352","journal-title":"Respir Med"},{"key":"1071_CR54","doi-asserted-by":"crossref","first-page":"192","DOI":"10.1016\/j.atherosclerosis.2016.06.027","volume":"251","author":"T Sugiura","year":"2016","unstructured":"Sugiura T, Dohi Y, Takase H, Yamashita S, Murai S, Tsuzuki Y, Ogawa S, Tanaka Y, Ohte N (2016) Serum levels of Mac-2 binding protein increase with cardiovascular risk and reflect silent atherosclerosis. Atherosclerosis 251:192\u2013196","journal-title":"Atherosclerosis"},{"key":"1071_CR55","doi-asserted-by":"crossref","first-page":"1044","DOI":"10.1016\/j.pan.2016.09.003","volume":"16","author":"Y Waragai","year":"2016","unstructured":"Waragai Y, Suzuki R, Takagi T, Sugimoto M, Asama H, Watanabe K, Kikuchi H, Hikichi T, Masamune A, Kang Y, Fleming JB, Ohira H (2016) Clinical significance of serum Wisteria floribunda agglutinin-positive Mac-2 binding protein in pancreatic ductal adenocarcinoma. Pancreatology 16:1044\u20131050","journal-title":"Pancreatology"},{"key":"1071_CR56","first-page":"4530","volume":"56","author":"H Inohara","year":"1996","unstructured":"Inohara H, Akahani S, Koths K, Raz A (1996) Interactions between galectin-3 and Mac-2-binding protein mediate cell-cell adhesion. Cancer Res 56:4530\u20134534","journal-title":"Cancer Res"},{"key":"1071_CR57","doi-asserted-by":"crossref","first-page":"1606","DOI":"10.1093\/emboj\/17.6.1606","volume":"17","author":"T Sasaki","year":"1998","unstructured":"Sasaki T, Brakebusch C, Engel J, Timpl R (1998) Mac-2 binding protein is a cell-adhesive protein of the extracellular matrix which self-assembles into ring-like structures and binds beta1 integrins, collagens and fibronectin. EMBO J 17:1606\u20131613","journal-title":"EMBO J"},{"key":"1071_CR58","doi-asserted-by":"crossref","first-page":"15690","DOI":"10.1074\/jbc.M200386200","volume":"277","author":"S Hellstern","year":"2002","unstructured":"Hellstern S, Sasaki T, Fauser C, Lustig A, Timpl R, Engel J (2002) Functional studies on recombinant domains of Mac-2-binding protein. J Biol Chem 277:15690\u201315696","journal-title":"J Biol Chem"},{"key":"1071_CR59","doi-asserted-by":"crossref","first-page":"483","DOI":"10.1016\/j.ijcard.2017.01.089","volume":"236","author":"K Nagao","year":"2017","unstructured":"Nagao K, Tamura A, Morimoto T, Shimamura K, Yukawa H, Ito H, Hayashi F, Makita T, Takemura G, Sato Y, Inada T, Kimura T, Tanaka M (2017) Liver fibrogenesis marker, 7S domain of collagen type IV in patients with acutely decompensated heart failure: correlates, prognostic value and time course. Int J Cardiol 236:483\u2013487","journal-title":"Int J Cardiol"},{"key":"1071_CR60","doi-asserted-by":"crossref","first-page":"552","DOI":"10.1016\/j.amjcard.2013.10.018","volume":"113","author":"T Taniguchi","year":"2014","unstructured":"Taniguchi T, Sakata Y, Ohtani T, Mizote I, Takeda Y, Asano Y, Masuda M, Minamiguchi H, Kanzaki M, Ichibori Y, Nishi H, Toda K, Sawa Y, Komuro I (2014) Usefulness of transient elastography for noninvasive and reliable estimation of right-sided filling pressure in heart failure. Am J Cardiol 113:552\u2013558","journal-title":"Am J Cardiol"}],"container-title":["Heart and Vessels"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s00380-017-1071-7\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00380-017-1071-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00380-017-1071-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,10,21]],"date-time":"2020-10-21T00:41:48Z","timestamp":1603240908000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s00380-017-1071-7"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,11,2]]},"references-count":60,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2018,4]]}},"alternative-id":["1071"],"URL":"https:\/\/doi.org\/10.1007\/s00380-017-1071-7","relation":{},"ISSN":["0910-8327","1615-2573"],"issn-type":[{"value":"0910-8327","type":"print"},{"value":"1615-2573","type":"electronic"}],"subject":[],"published":{"date-parts":[[2017,11,2]]}}}